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DEFINITION AND HI STORICAL ASPECTS 
Angioedema is usually regarded as a peculia r 
condition appearing sudden ly as a subcutaneous, 
loca li zed swelling on one or more parts of the body. 
It was first described by Quincke (1882) and give n 
t he name angioneu rotic edema by Strub ing (1885). 
The underlying mechanism responsi ble for t hi s 
condition was thought to be a vasomotor disturb-
ance of the blood vesse ls of the subcutaneous and 
submucosal tissues, giving rise to increased capil-
lary permeability and edema (angioneurosis). T he 
factors that regulated and cont rolled this condition 
were, however, not understood. 
Shortly after Quincke's description, Dinken-
lacher (1882), one of his students, observed the 
disease in a watchmaker who had been affected by 
transient local swellings on his skin for many years; 
this man had a son who was a lso affected from 
early infancy. Three years later another son was 
born and was reported to be affected from t he first 
week of his life . In 1888, Osler first ca ll ed attention 
in th is country to the existence of a hereditary form 
of angioedema, transmitted as a mendelian domi -
nant trait by affected members to consecutive 
generations. 
Affected individuals have recurrent attacks of 
circumscribed edema involving the skin, subcu-
taneous t issue, and mucous membranes anywhere 
in t he body, espec ia lly in those lining the pharynx , 
larynx, and gastrointestinal tract. The localized 
edema of the skin is nonpitt ing and nonpruritic, 
genera lly in volves part of the face or an extremity, 
is frequently precipitated by direct trauma, and is 
rarely preceded by or assoc iated with serpiginous 
edema. Concurrent or isolated involvement of the 
gastrointestinal t ract, compounded by nausea, 
vomiting, or coli c, may lead to surgica l interven-
tio n, a lthough fever and leukocytosis are always 
absent. There is a high mortality rate in patients 
affected by acute la ryngea l edema. Because of the 
poor prognosis for life in a ngioedema of the hered i-
tary type, compared with t he nonheredita ry form 
of the disease of a ll ergic or unknown et iology, it is 
critica l to recognize this entity without depending 
on a fami ly history involving several generations. 
The first indication of a hered itary biochemical 
ab normali ty unique to t hese patients was the 
report of Landerman et al. (1962) of a defic iency of 
a serum inhibitor of kallikrein and PF dil. This was 
followed by the observation of Donalson and Evans 
(1963) that t he serum alpha 2 -globulin inhi bitor of 
the first component (C1) of the complement sys-
tem was functiona lly absent. It is now clear that 
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both laboratories had di scovered different mani-
festations of the sa me protein defi c iency (Gigli et 
al., 1970). 
PATHOGENES IS 
The absence of a functional serum inhibitor of 
t he complement and the kinin systems in the 
serum of patients with hereditary angioedema 
(HAE) suggests the participation of both syste ms 
in the pathogenesis of the di sease. However, de-
spite some information about the mediators of the 
angioedema and the biochemica l events involved 
in the initiat ion of the attacks, the mecha nis m 
involved has not yet been complete ly elucidated. 
To appreciate these findings, we must briefly 
review certain aspects of the comp lement and 
kinin systems. 
The co mplement system consists of nine distinct 
serum p roteins (Muller-Eberhard, 1968; Ne lson et 
a l. , 1966) numbered 1 through 9, which interact in 
a sequentia l order so as to be cytotox ic for target 
cells and to produce a series of by-products that are 
essentia l ingredients of the infl a mmatory response 
(F ig. 1). When an immune agg regate or a target 
cell sensitized by in teraction with specific anti-
body against some cell-surface antigen interacts 
with normal serum in the presence of ca lcium ions 
the first component of comple ment is bound and 
converted from an inactive precursor form (Cl) to 
an active enzyme (CJ). The activation of C1 to CI 
either in the fluid phase or bound to a complex: 
results in esterase activ ity on synthetic amino acid 
ester substrates, p-toluene sulfonyl L-arginine 
methyl ester (TAMe), or N-acetyl-tyrosine ethyl 
ester (ATEe), and on its natural substrates, the 
fourth (C4) and · the second (C2) components of 
complement. These functions of CT are susceptibl e 
to inhibition by an a lpha 2-glob ulin in normal 
serum, the CT inhibi tor (CTINH) (Levy and Le-
pow, 1959; Lepow and Leon , 1962). 
The action of CT on C4 and C2 generates from 
t hese components a new enzymatic activity, C3 
convertase, consisting of a fragment of C4, C4i, and 
a fragment of C2, C2a. This enzyme, which re-
quires magnesium ions for its formation , can be 
produced in t he fluid phase, but it is more effi-
ciently assembled on a ce ll su rface (Muller-Eber-
hard, 1968). Through t he action of C3 convertase 
on C3, a portion of the C3 molecule (C3b) is bound 
to the complex, releasing a smaller fragme nt, C3a 
into the fluid phase. This fragment has ana : 
phylatoxin activity (Dias da Si lva) and Lepow, 
1967). T he presence of C3b on the complex confers 
on it the ab ili ty to participate in the immune-ad-
herence phenomenon, a reaction in which the com-
plex, having achieved the T, 4, 2, 3b state, binds to 
a specific receptor s ite on primate erythrocytes or 
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FIG. 1. The complement react ion seq uence. 
polymorphonuclear leukocytes (Ne lson , 1965) . 
This phenomenon is t hought to initiate phagocyto-
sis by polymorphonuclear leukocytes (Gigli and 
Nelson, 1968). The subsequent in teraction of t he 
fifth (C5) component of complement wit h t he 
complex yields a fragment with biologic activ it ies 
(C5a). The production of a chemotactic facto r and 
an anaphylatoxin (Jensen, 1967; Ward et al. , 1965) 
has been reported to be associated with this 
reaction. The mechanism involved in the act iva-
tion of C6 a nd C7 has been less well studi ed. Both 
of these components are physically bound to t he 
complex a nd, in the course of these react ions, a 
chemotactic factor for polymorphonuclear leuko-
cytes is generated (Cochra ne a nd M uller-Eber-
hard, 1968). The add ibion of the eighth (C8) and 
the ninth (C9) components leads to osmotic lysis of 
the target cell with t he appearance of discontinui -
ties of t he ce ll membrane as seen on electron 
microscopy (Humphrey and Dourmashkin , 1965). 
The absence of a functiona l CTINH in angio-
edema of the hereditary type affords a genetic 
marker characteristic of this disease; in add ition , it 
introduces the possibility t hat t he activity of 
uninhibited CT is involved in the pathogenesis of 
the attacks. Patients wit h HAE are continuously 
subjected to the act ion of low leve ls of act ivated 
CT, as evident from chronica lly reduced levels of 
C4 (Ruddy et al., 1968) and markedly increased 
catabolism of radiolabeled C4 (Carpente r et al. , 
1969). Clinica l attacks are associated with the 
appearance of serum esterase act ivity against N-
acety 1 L-tyrosine ethyl ester (Dona ldson and ~osen , 
1964)- C4 and C2, t he natural substrates of Cl , are 
reduced in activity, even during asymptomatic 
interva ls, and further reductions a re associated 
with c linica l attacks (Austen and S heffer, 1965; 
Ruddy and Austen , 1967) . In addit ion, evidence for 
local activation of Cl has been found in the venous 
blood draining from a single in volved extrem ity. 
The reasons for t he ep isodic activation of Cl are 
not known , but it seems clea r that activation of Cl 
accompa nies attacks of HAE. 
When purified CT, isolated from hea lt hy donors, 
is injected into the skin of normal volunteers, a n 
in tense wheal deve lops , whereas the intraderma l 
injection into patients with HAE precipitates a 
loca l attack of angioedema . Sim ilar injections into 
individua ls homozygous for C2 deficiency fail to 
ca use a response , even when the dose is ten t imes 
that which eli cits a permeability change in norma l 
subjects (K lemperer et a!. , 1968). From these 
studies, we can infer that uninhibited CT can eli cit 
angioedema t hrough a reaction sequence that in -
volves at least one of its natural substrates, C2. 
These data can be interpreted to implicate the 
for mation of anaphylatox in , with histamine rel ease 
as the responsibl e media tor for the angioedema; 
however, antihistamines are of no clinical benefit 
in HAE, eit her during the attack or to suppress the 
local increase of vascular permeability that fo llows 
in tradermal injection of C1 (Klemperer et a l. , 
1968). Moreover, the activities of C3, C5, C6, C7, 
CB, and C9 measured individually in patients with 
HAE do not appear to be reduced (Ruddy et a l. , 
1968) , and fo llowing the intradermal injection of 
CT, patients with an acquired deficiency of C3 
reacted norma lly when tested for their abi li ty to 
generate t his complement-dependent vasopermea-
bility response. The precise chem ica l nature of the 
mediator of HAE remains unknown . Donaldson et 
a l. (1968) have reported a sma ll molecular weight 
factor which appears in HAE plasma upon incuba-
tion. Present data suggest t hat this factor is the 
product of t he act ion of uninhibited CT on its 
natural substrates C4 and C2 (Klemperer et a l. , 
1969). Although t his material resembles bradyki-
nin , it differs from t he kinins by its marked 
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susceptibi li ty to degradation by trypsin and chy-
motrypsin and from anaphylatox in by its heat 
stab ility. 
In considering the pathogenesis of the disease, 
we must apprec iate that CTINH inhibits t he action 
of kallikrein on t he synthetic substrate esters, 
p-toluene sulfonyl L-arginine methyl ester (Kagan, 
1964) and t hat HAE plasma lacks this inhibi tory 
activity (Landerman et a !. , 1962) . Gigli et a!. 
(1970) have demonstrated that the consumption of 
CTINH during interaction with purified kallikrein 
exhibits a concentrat ion and time dependence 
similar to its interaction with CT. In add it ion to its 
action on CT, the CTINH participates in the con-
t rol of the coagu lat ion and fibrinolytic systems. It 
inhibits the capacity of active Hageman factor, or 
its fragments, to induce t he conversion of prekal-
likrein to kallikrein , of plasminogen proactivator to 
plasminogen activator, and of precursor plasma 
thrombop last in antecedent to its active form (PTA) 
(Schre iber et al., 1973). Kallikrein (Gigli et al., 
1970) , plasmin and PTA (Ratnoff eta!. , 1969) have 
a lso been shown to be inhibi ted by CTINH. These 
results , together with the findings of Donaldson et 
al. (1969), in which soy bean trypsin inhibitor in ter-
feres with the generation of the permeability factor 
in HAE plasma, implicates the participation of 
serum enzymes such as kallikrein and plasmin. 
It has been shown in vitro that activation of 
Hageman factor plays a role in the activation of C1 
(Fig. 2) . Hageman factor initiates the in trinsic co-
agu lation pathway (Ratnoff, 1961 ; Macfarlane, 
1964). This in turn leads to the conversion of 
plasminogen to the fibrinolytic enzyme plasmin 
(McDonagh and Ferguson, 1970), with the subse-
quent generation of bradykinin in human plasma 
(Margolis, 1958; Webster and Ratnoff, 1961). Di-
gestion of activated Hageman factor by plasmin 
li berates Hageman factor fragments , which possess 
greater capac ity than the parent molecule to con-
vert prekallikrein to kallikrein, the enzyme which 
digests kininogen to liberate bradykinin (Kaplan 
and Aus ten, 1970, 1971). The ready activation of 
the kinin system in response to nonspecific tissue 
injuries may not on ly yield t he vasoactive peptide 
bradykinin but a lso recruit the complement sys-
tem, possibly t hrough an act ion of kallikrein on Cl. 
Moreover, t he activation of plasminogen to plas-
min in the absence of CTINH may a ll ow t he latter 
to activate C1 and initiate the sequence leading to 
an attack (Ra tnoff and N aff, 1967). 
GENETIC CONSIDERATIONS 
Well over 100 families with deta iled family 
histories of HAE have been reported in t he li tera-
ture (Landerman, 1962). In 32 of these kindreds 
the functional absence of the CTINH has bee~ 
confirmed by laboratory methods (Ruddy and 
Gigli, 1967) . The proportion of affected to nonaf-
fected offsp rin g seems to confirm t he earlier sug-
gestion that t he disease is inheri ted as an a utoso-
mal dominant with incomplete penetrance, in 
which affected individuals are heterozygotes. Usu-
a ll y the dominance is regular, with the affected 
members transmitting the disease to about half of 
their children (Fig. 3). A generation has been 
skipped in on ly five fam ilies, in which the disease 
was apparen t ly passed on by normal parents. 
Iso lated cases without family history are probably 
random mutations and may potentially lead to 
new family lines of t he disease (W hiting, 1908). 
The inheritance is nonsex- linked since the disease 
can be t ransmitted eq ually well by male or female 
patients. HAE has occurred in American Negroes 
English, Scotch- Irish , Swedish, Italian, Dutch : 
French , Sepha rdic and Ashkenasy Jews, a nd Turk-
ish Armenians. 
In the common form of HAE, affected individu-
a ls have reduced leve ls of CTINH in the serum 
eit her as act ivity in the hemolytic system (Gigli et 
a !. , 1968) or as a protein in the radial immunodiffu-
sion assay. Most affected individua ls have some 
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FIG. 2. Participation of the kinin and complement systems in the pathophysiology of hereditary a ngioedema. 
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immunochemica lly detectable CTINH , a nd serum 
levels for a ny give n affected individ ua l are rela-
t ively constant . 
T he mecha nism for reduced CTINH levels in 
HAE seems to reside in a n impairment of CTINH 
syn t hesis. By immunofl uorescent techniques, the 
h epatic parenchymal cell has been identified as t he 
s ite of synt hesis of CTINH. Three to four percent of 
normal hepatic cells flu oresced with monospecific 
a n tiserum to CTINH, whereas no fluorescen t cells 
w~re fo und in liver biopsies of two HAE patients 
Wit h t he common form of t he disease (J ohnson et 
al. , 1971). 
F ifteen percen t of a ll affected kindred wi th HAE 
c~nta in an a nt igenically intact but nonfunctiona l 
CliNH protein , which is present in normal or 
in cr eased qua nt it ies (Rosen et al. , 1965). This 
p rotein is immunochemica lly ident ica l with t he 
nor ma l, but t he electrophoretic mobi lity is a bnor-
mal in that HAE serum yields single a rcs of 
prec ipi tat ion, whereas norma l serum reacts with 
spec ific an t ibody to produce a double arc (Rosen et 
a!. , 1965). F urther variations have been noted 
a~ong ~hese ab norma l prote ins in their ca pacity to 
bmd C1 (Rosen et a l. , 1971) and to inhibi t 
ka ll i k rei n (Gigli et al. , 1970). Of eleven fa milies 
with t his "genetic varia nt" form of t he disease, the 
a~ected sera in eigh t conta ined norma l a moun ts of 
CllN H , whereas in the other t hree t he CTINH 
con tent was three to fo ur times greater tha n t he 
normal. Studies of the CTINH protein have dem-
on strated un ique mobili ties for each fa mily, whic h 
are consta nt for all affected members of the kin-
dre d. T he genetic variant form of HAE a lmost 
certa inly represents structural mu tations. 
PATHOLOGY AN D PROGNOS IS 
T h e pathologic changes t hat take place in HAE 
have been described from t issues of affected indi -
vidu a ls obtained by cutaneous and jejunal biop-
sies, at laparotomies, a nd a utopsies (S heffer et a l. , 
1969; B iering, 1956) . The cha nges in t he skin 
con s isted of subcutaneous edema, with large in-
t ere ndothelia l ce ll gaps in t he postcapillary ven-
ules . U pper respiratory t ract involvement revea led 
massive edema of t he laryngeal mucosa, sub-
mucosa , and underlying muscle, wit hout signifi-
ca nt part icipation of infla mmatory cells or eosino-
phils (Gri ffith, 1902; Morris, 1905). Spongiosis of 
the mucosal epit helial cells with the formation of 
cytoplasmic vacuoles was noted. The lungs of a 
patient who died of laryngea l edema showed dif-
fuse edema a nd hemorrhage, most probably sec-
ondary to asphyxiation (G riffi th, 1902). 
Quincke (1882) was the first to suggest t hat t he 
abdomina l symptoms were due to loca li zed edema 
and obstruction in the gastroin testinal t ract. 
Lundback (1 940) , on direct gastroscopic examina-
t ion, observed marked gastric mucosa l edema and 
hyperemia during an attack. J ejuna l t issue demon-
strated edema of t he la mina propia , involving t he 
superficial port ion of the villi and giving rise to a 
club-shaped appearance wi thout submucosa l 
edema. The findin gs described in HAE . oiffered 
from those of systemic anaphylaxis in that in the 
latter the involved orga ns conta ined an inflam ma-
tory infil t rate with large numbers of eosinophils 
(Ja mes and Austen, 1964). 
A large number of patients with clinica l manifes-
tat ions of HAE may eventually di e from acute 
la ryngea l edema. Of 358 cases reported by Lander-
man (1962), 119 d ied; 92 of t hese deaths were 
attributed to laryngeal edema. T he age of death 
was noted in 48 cases; 26 deaths occurred in 
patients who were less than 30 years old . The 
average age of death was 35 years, wit h a range 
from 14 mont hs to 70 years. 
LABO RATORY DI AGNOS IS OF HEREDITARY ANGIOEDEMA 
T he defini t ive diagnosis of HAE requires t he 
demonstration of the fu nctional a bsence of t he 
CTINH. Curre ntly, numerous diffe rent laboratory 
procedures can reveal t he integrity of t he alpha- 2 
globulin inhib itor of CT. Of the t hree methods 
avail able (Ruddy et a l. , 1967) , the quant itative 
m easurement of the Cl inhibitor protein by double 
immunodiffusion in Ouchterlony plates detects 
most of the patients with HAE (Rosen et al. , 1965) . 
The concentration of this protein , 2.4 ± 0.4 mg per 
100 ml in normal serum is reduced to < 0.64 
mg per 100 ml in the serum of patients wi t h HAE. 
In those kindreds with t he genetic variant , normal 
or elevated concent rations of inhib itor p rotein 
a re detected. A second direct assay , a biochemica l 
method , applies t he knowledge t hat CTINH , which 
is present in normal serum , will block t he splitting 
of a syn thetic a mino acid ester substrate , N -acetyl 
L- tyrosine ethyl este r, by CT. Donaldson and Evans 
(1963), using an ada ptation of a n assay desc ribed 
by Levy and Lepow found 5.8 ± 1.8 inhi bitor uni ts 
per ml in norma l huma n serum but practica lly 
none in the serum of patients with HAE. T he t hird 
direct assay utilizes the a bili ty of t he CTINH to 
block t he action of CT in immune he molysis; t he 
mean plus two standard deviations of t he inhibi tor 
concentration is 37,445 ± 17 ,790 units per ml (Gigli 
et a!. , 1968). 
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The measurements of reduced levels of t he two 
natural substrates of CT, C4 and C2, are reliable, 
indirect screen ing devices for t his biochemical 
defect. In the absence of CTINH, the unopposed 
action of CT on these two complement components 
diminishes t he ir serum concentra tion . The titer of 
C2 in 14 patients from five kindreds ranged from 
less than 5 units to 325 units during asymptomatic 
periods . During clinical attacks of HAE, C2 virtu-
ally disappears (Austen a nd Sheffer, 1965), a n 
indication of further endogenous activat ion of the 
uninhibited enzyme , CT. 
The measurement of C4 (Ruddy and Austen , 
1967) , e ither hemoly tica lly or in protein con centra-
tion , has advantages over the assay for C2. Of 
these, the C4 prote in (/11.) determination is the 
s implest screening test a vaila ble (Ruddy and Aus-
ten , 1967). In a study that included both normal 
individuals and patients with HAE, an excellent 
correlation was found between the results of the 
h emolyt ic assay for C4 and the radia l immunodif-
fusion assay for C4 protein. Of 115 members of 19 
kindreds, a ll 47 members shown to lack CTINH by 
either biochemical or t he immunodiffus ion assay 
have been found to have C4 titers below the limi ts 
determined in 62 normals (37,445 units per ml ± 
17, 790). Since diseases other than HAE can cause 
reduced levels of C4, t h e finding of s uch reductions 
requires the use of a direct test for CTINH. If C4 is 
reduced and the CTINH is presen t by immunod if-
fus ion, diagnostic confirmation with either the bio-
chemical or hemolytic assay must rely on t he 
demonstration of a nonfunctional CTINH prote in. 
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